Terms: = Thyroid cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Staging
5 results:
1. Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study.
Wang Y; Qiao L; Yang J; Li X; Duan Y; Liu J; Chen S; Li H; Liu D; Fang T; Ma J; Li X; Ye F; Wan J; Wei J; Xu Q; Guo E; Jin P; Wu M; Zhang L; Xia Y; Wu Y; Shao J; Feng Y; Zhang Q; Yang Z; Chen G; Zhang Q; Li X; Wang S; Hu J; Wang X; Tan MP; Takabe K; Kong B; Yang Q; Ma D; Gao Q
Cancer Commun (Lond); 2021 Dec; 41(12):1373-1386. PubMed ID: 34738326
[TBL] [Abstract] [Full Text] [Related]
2. The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice.
Kaliszewski K; Diakowska D; Nowak Ł; Wojtczak B; Rudnicki J
BMC Cancer; 2020 Nov; 20(1):1166. PubMed ID: 33256657
[TBL] [Abstract] [Full Text] [Related]
3. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract] [Full Text] [Related]
4. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract] [Full Text] [Related]
5. [Bone marrow changes in patients with thyroid carcinoma].
Linden A; Weiss R; Smolarz K; Jungehülsing M; Theissen P; Schicha H
Nuklearmedizin; 1991 Dec; 30(6):272-8. PubMed ID: 1780240
[TBL] [Abstract] [Full Text] [Related]
